ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
약물감시 시장 규모는 최근 급성장하고 있습니다. 2025년 96억 4,000만 달러에서 2026년에는 108억 6,000만 달러에 이르고, CAGR 12.7%의 성장이 전망되고 있습니다. 지난 수년간의 성장은 부작용 보고 증가, 세계 의약품 승인 확대, 임상시험 건수 증가, 국제 의약품 안전 규제 확립, 만성질환 치료제의 사용 확대 등이 요인으로 꼽힙니다.
약물감시 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 174억 1,000만 달러에 이르고, CAGR은 12.5%를 나타낼 전망입니다. 예측 기간 동안의 성장에는 실제 데이터(RWD) 활용 확대, 생물학적 제제 및 바이오시밀러 승인 증가, 병용 요법의 복잡성 증가, 신흥 시장에서의 약물감시 확대, 환자 안전 결과에 대한 관심 증가 등이 영향을 미칠 것으로 보입니다. 예측 기간의 주요 동향으로는 시판 후 조사 활동의 확대, 안전성 모니터링에 대한 실제 데이터 채택 증가, 규제 당국의 감시 강화 및 컴플라이언스 요구 사항 증가, 의약품 안전성 모니터링 서비스 아웃소싱 증가, 다출처 안전성 데이터 플랫폼의 통합 등이 있습니다.
연구개발(R&:D) 활동 증가는 의약품 안전성 모니터링 시장의 성장을 견인할 것으로 예측됩니다. 제약기업은 연구개발에 대한 투자를 통해 안전성 프로파일이 개선된 신약을 개발할 수 있습니다. 의약품 개발 단계의 엄격한 비임상 및 임상시험을 통해 잠재적인 안전성 문제를 조기에 파악할 수 있고, 효과적인 위험 감소 전략을 실행할 수 있습니다. 또한, R&&D는 부작용 모니터링, 데이터 분석, 신호 감지 기술의 발전을 지원하여 시판 후 단계에서 부작용을 적시에 파악할 수 있도록 돕습니다. 예를 들어, 영국 통계청(ONS)에 따르면, 2023년 영국 정부의 연구개발(R&&D) 순지출은 2022년 161억 파운드에서 174억 파운드로 8.2% 증가할 것으로 예상했습니다. 이처럼 연구개발 활동의 확대는 의약품 안전성 모니터링 시장의 성장을 가속하고 있습니다.
의약품 안전성 모니터링 시장의 주요 기업들은 업무 효율성과 정확성을 높이기 위해 인공지능(AI)을 활용하고 있습니다. AI는 의약품 안전성 모니터링 프로세스를 효율화하고, 데이터 관리를 강화하며, 신호 감지를 가속화하고, 궁극적으로 환자의 안전과 치료 결과를 개선하는 데 기여할 수 있습니다. 예를 들어, 2024년 8월 인도 정부는 보건가족복지부 장관과 화학비료부 장관이 도입한 '약물유해반응 모니터링 시스템(ADRMS)' 소프트웨어를 출시하였습니다. 이 약물감시 플랫폼은 의약품 및 의료기기 관련 부작용의 수집 및 분석을 촉진하고, 의료 종사자 및 소비자의 보고 프로세스를 간소화합니다. ADRMS는 종합적인 안전성 데이터 수집을 보장하고, 규제 준수를 강화하며, 세계 제약 산업에서 인도의 위상을 뒷받침함으로써 인도의 약물감시 기반을 강화할 것입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
Pharmacovigilance is the science and practice of identifying, evaluating, understanding, and mitigating side effects and other issues related to drugs or vaccines. It helps determine whether a medication's benefits outweigh its risks and continues beyond the point of drug approval.
The main types of pharmacovigilance include spontaneous reporting, intensified ADR reporting, targeted spontaneous reporting, cohort event monitoring, and EHR mining. Spontaneous reporting is a passive method that relies on individuals to voluntarily report suspected adverse drug reactions to local or national pharmacovigilance centers. Key process flows involve case data management, signal detection, and risk management systems. Service providers can be in-house or contracted for outsourcing, covering clinical trial phases such as preclinical, Phase I, Phase II, Phase III, and Phase IV. These services are utilized by hospitals, pharmaceutical companies, and other healthcare organizations.
Tariffs have moderately impacted the pharmacovigilance market by increasing the cost of imported IT infrastructure, data management software, and specialized safety monitoring tools used across global operations. These cost pressures particularly affect contract outsourcing providers and EHR mining segments, with Asia-Pacific and parts of Europe experiencing higher operational expenses due to reliance on cross-border technology services. Clinical trial phase IV activities and advanced signal detection processes are also influenced by delayed system upgrades. However, tariffs have encouraged local deployment of pharmacovigilance platforms, regional service partnerships, and investment in domestic data processing capabilities, supporting long-term market resilience.
The pharmacovigilance market research report is one of a series of new reports from The Business Research Company that provides pharmacovigilance market statistics, including pharmacovigilance industry global market size, regional shares, competitors with a pharmacovigilance market share, detailed pharmacovigilance market segments, market trends and opportunities, and any further data you may need to thrive in the pharmacovigilance industry. This pharmacovigilance market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pharmacovigilance market size has grown rapidly in recent years. It will grow from $9.64 billion in 2025 to $10.86 billion in 2026 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to increasing adverse drug reaction reporting, expansion of global pharmaceutical approvals, rising clinical trial volumes, establishment of international drug safety regulations, growth in chronic disease drug usage.
The pharmacovigilance market size is expected to see rapid growth in the next few years. It will grow to $17.41 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to real-world data utilization growth, rising biologics and biosimilars approvals, increasing complexity of combination therapies, expansion of pharmacovigilance in emerging markets, growing focus on patient safety outcomes. Major trends in the forecast period include expansion of post-marketing surveillance activities, growing adoption of real-world evidence in safety monitoring, increasing regulatory scrutiny and compliance requirements, rising outsourcing of pharmacovigilance services, integration of multisource safety data platforms.
The increasing research and development (R&D) activities are expected to drive the growth of the pharmacovigilance market. By investing in R&D, pharmaceutical companies can develop new drugs with improved safety profiles. Rigorous preclinical and clinical testing during drug development enables the early identification of potential safety concerns, allowing for the implementation of effective risk mitigation strategies. Additionally, R&D supports the advancement of technologies for adverse event monitoring, data analysis, and signal detection, facilitating the timely identification of adverse drug reactions in the post-marketing phase. For instance, in 2023, according to the Office for National Statistics, a UK-based government agency, the UK government's net spending on R&D increased to £17.4 billion in 2023, up from £16.1 billion in 2022, marking an 8.2% rise. Therefore, increasing R&D activities are fueling the growth of the pharmacovigilance market.
Key companies in the pharmacovigilance market are leveraging artificial intelligence (AI) to improve operational efficiency and accuracy. AI streamlines pharmacovigilance processes, enhances data management, accelerates signal detection, and ultimately contributes to better patient safety and outcomes. For example, in August 2024, the Government of India launched the Adverse Drug Reaction Monitoring System (ADRMS) software, introduced by the Minister of Health & Family Welfare and the Minister of Chemicals and Fertilizers. This pharmacovigilance platform facilitates the collection and analysis of adverse events related to medicines and medical devices, simplifying the reporting process for healthcare professionals and consumers. ADRMS strengthens India's pharmacovigilance infrastructure by ensuring comprehensive safety data capture, enhancing regulatory compliance, and supporting the country's position in the global pharmaceutical industry.
In January 2023, AmerisourceBergen, a US-based pharmaceutical wholesale company, acquired Pharma Lex for an undisclosed amount. This acquisition expands AmerisourceBergen's capabilities in supporting pharmaceutical and biotechnology companies across the product lifecycle. Pharma Lex, a Germany-based company, provides end-to-end pharmacovigilance solutions, including systems and operations management as well as benefit-risk assessment services, enhancing the overall safety monitoring infrastructure for its clients.
Major companies operating in the pharmacovigilance market are IQVIA, Cognizant, ICON Plc, Accenture plc, PAREXEL International Corporation, United BioSource LLC, ArisGlobal, Quanticate, Wipro Limited, Linical Americas, Novotech CRO, EXTEDO, Arriello, PrimeVigilance, Axios International, C3i Solutions, Secure AI Labs, OmniSol dot Tech, Prevnos Inc., Lifescient Inc, QuintilesIMS, Labcorp Drug Development, Pharmaceutical Product Development Inc., PRA Health Sciences, Synowledge LLC, RAPAhub, illuminate health, Invenio Medical, ClinChoice Inc., Novasyte, Fortrea Holdings Inc., Syneos Health Clinical, Telerx Marketing Inc.
North America was the largest region in the pharmacovigilance market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the pharmacovigilance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The pharmacovigilance market includes revenues earned by collecting, analyzing, monitoring, and preventing adverse effects in drugs and therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pharmacovigilance Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses pharmacovigilance market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for pharmacovigilance ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmacovigilance market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Type: Spontaneous Reporting; Intensified ADR Reporting; Targeted Spontaneous Reporting; Cohort Event Monitoring; EHR Mining
2) By Service Provider: In-House; Contract Outsourcing
3) By Process Flow: Case Data Management; Signal Detection; Risk Management System
4) By Clinical Trial Phases: Preclinical; Phase I; Phase II; Phase III; Phase IV
5) By End User: Hospitals; Pharmaceutical Companies; Other End Users
Subsegments:
1) By Spontaneous Reporting: Individual Case Safety Reports (ICSRs); Voluntary Reporting Systems; Case Reports From Healthcare Professionals
2) By Intensified ADR Reporting: Active Surveillance Programs; Enhanced Monitoring In Clinical Trials; Risk Minimization Strategies
3) By Targeted Spontaneous Reporting: Reporting For Specific Drug Classes; Condition-Specific Reporting; Focused Surveillance Programs
5) By EHR Mining: Data Extraction From Electronic Health Records; Signal Detection Through EHR Analysis; Integration Of EHR Data With Pharmacovigilance Systems
Companies Mentioned: IQVIA; Cognizant; ICON Plc; Accenture plc; PAREXEL International Corporation; United BioSource LLC; ArisGlobal; Quanticate; Wipro Limited; Linical Americas; Novotech CRO; EXTEDO; Arriello; PrimeVigilance; Axios International; C3i Solutions; Secure AI Labs; OmniSol dot Tech; Prevnos Inc.; Lifescient Inc; QuintilesIMS; Labcorp Drug Development; Pharmaceutical Product Development Inc.; PRA Health Sciences; Synowledge LLC; RAPAhub; illuminate health; Invenio Medical; ClinChoice Inc.; Novasyte; Fortrea Holdings Inc.; Syneos Health Clinical; Telerx Marketing Inc.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
4.1.3 Biotechnology, Genomics & Precision Medicine
4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.1.5 Industry 4.0 & Intelligent Manufacturing
4.2. Major Trends
4.2.1 Expansion Of Post-Marketing Surveillance Activities
4.2.2 Growing Adoption Of Real-World Evidence In Safety Monitoring
4.2.3 Increasing Regulatory Scrutiny And Compliance Requirements
4.2.4 Rising Outsourcing Of Pharmacovigilance Services
4.2.5 Integration Of Multisource Safety Data Platforms
5. Pharmacovigilance Market Analysis Of End Use Industries
5.1 Pharmaceutical Companies
5.2 Hospitals
5.3 Biotechnology Companies
5.4 Contract Research Organizations
5.5 Academic And Research Institutes
6. Pharmacovigilance Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Pharmacovigilance Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Pharmacovigilance PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Pharmacovigilance Market Size, Comparisons And Growth Rate Analysis
7.3. Global Pharmacovigilance Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Pharmacovigilance Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Pharmacovigilance Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Pharmacovigilance Market Segmentation
9.1. Global Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.2. Global Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
In-House, Contract Outsourcing
9.3. Global Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Case Data Management, Signal Detection, Risk Management System
9.4. Global Pharmacovigilance Market, Segmentation By Clinical Trial Phases, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Preclinical, Phase I, Phase II, Phase III, Phase IV
9.5. Global Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Pharmaceutical Companies, Other End Users
9.6. Global Pharmacovigilance Market, Sub-Segmentation Of Spontaneous Reporting, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals
9.7. Global Pharmacovigilance Market, Sub-Segmentation Of Intensified ADR Reporting, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies
9.8. Global Pharmacovigilance Market, Sub-Segmentation Of Targeted Spontaneous Reporting, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs
9.9. Global Pharmacovigilance Market, Sub-Segmentation Of Cohort Event Monitoring, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Pharmacovigilance Market
12.1. China Pharmacovigilance Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Pharmacovigilance Market
13.1. India Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Pharmacovigilance Market
14.1. Japan Pharmacovigilance Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Pharmacovigilance Market
15.1. Australia Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Pharmacovigilance Market
16.1. Indonesia Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Pharmacovigilance Market
17.1. South Korea Pharmacovigilance Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Pharmacovigilance Market
18.1. Taiwan Pharmacovigilance Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Pharmacovigilance Market
19.1. South East Asia Pharmacovigilance Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Pharmacovigilance Market
20.1. Western Europe Pharmacovigilance Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Pharmacovigilance Market
21.1. UK Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Pharmacovigilance Market
22.1. Germany Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Pharmacovigilance Market
23.1. France Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Pharmacovigilance Market
24.1. Italy Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Pharmacovigilance Market
25.1. Spain Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Pharmacovigilance Market
26.1. Eastern Europe Pharmacovigilance Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Pharmacovigilance Market
27.1. Russia Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Pharmacovigilance Market
28.1. North America Pharmacovigilance Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Pharmacovigilance Market
29.1. USA Pharmacovigilance Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Pharmacovigilance Market
30.1. Canada Pharmacovigilance Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Pharmacovigilance Market
31.1. South America Pharmacovigilance Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Pharmacovigilance Market
32.1. Brazil Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Pharmacovigilance Market
33.1. Middle East Pharmacovigilance Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Pharmacovigilance Market
34.1. Africa Pharmacovigilance Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Pharmacovigilance Market Regulatory and Investment Landscape
36. Pharmacovigilance Market Competitive Landscape And Company Profiles
36.1. Pharmacovigilance Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Pharmacovigilance Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Pharmacovigilance Market Company Profiles
36.3.1. IQVIA Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Cognizant Overview, Products and Services, Strategy and Financial Analysis
36.3.3. ICON Plc Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Accenture plc Overview, Products and Services, Strategy and Financial Analysis
36.3.5. PAREXEL International Corporation Overview, Products and Services, Strategy and Financial Analysis
37. Pharmacovigilance Market Other Major And Innovative Companies
